Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05499702
PHASE2

The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction

Sponsor: Adrian Vella

View on ClinicalTrials.gov

Summary

Caloric restriction (and RYGB) improves insulin action and lowers fasting glucose, glucagon and EGP, without changes in postprandial EGP and glucagon concentrations. Caloric restriction also improves hepatic steatosis and lowers fasting AA. These changes may represent restoration of glucagon's hepatic actions. This experiment will determine whether caloric restriction improves glucagon's actions on hepatic amino acid, carbohydrate and lipid metabolism in T2DM in comparison to a baseline experiment performed separately in people with T2DM.

Key Details

Gender

All

Age Range

25 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2022-12-15

Completion Date

2026-12-31

Last Updated

2025-06-04

Healthy Volunteers

No

Conditions

Interventions

BEHAVIORAL

Caloric Restriction

Subjects will be instructed to consume a diet of 900 kcal daily using meals derived from "Nutritional Guidelines after Bariatric Surgery". Compliance will be monitored by weekly meetings with the dietician using an electronic record of food intake

DRUG

Hyperglycemic clamp

Hyperglycemic clamp to measure the effect of glucagon on hepatic metabolism

Locations (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States